63-056-642

CD56 (NCAM) Monoclonal Antibody (TULY56), Super Bright™ 600, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 63-056-642-Each-of-1 In Stock ₹ 33,642.00

63-056-642 - Each of 1

₹ 33,642.00

In Stock

Quantity

1

Base Price: ₹ 33,642.00

GST (18%): ₹ 6,055.56

Total Price: ₹ 39,697.56

Antigen

CD56 (NCAM)

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with BSA and 0.09% sodium azide

Gene Accession No.

P13591

Gene Symbols

Ncam1

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

4684, 693789

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

TULY56

Conjugate

Super Bright 600

Gene

Ncam1

Gene Alias

adhesion molecule; antigen recognized by monoclonal antibody 5.1H11; Cd56; CD-56; CD56 120 kDa GPI-linked isoform; CD56 140 kDa isoform; CD56 140 kDa VASE isoform; E NCAM; E-NCAM; MSK39; N CAM1; NCAM; N-CAM; Ncam1; N-CAM-1; NCAM-1; NCAMC; NCAM-C; neural cell adhesion molecule; Neural cell adhesion molecule 1; neural cell adhesion molecule, NCAM; sCD56; sNCAM; soluble CD56; soluble NCAM

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human, Non-human Primate, Rhesus Monkey

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

67056642

--

Img

Invitrogen

56-054-941

--

Img

Invitrogen

50-177-98

--

Img

Invitrogen

63-031-942

--

Img

Invitrogen

63-166-842

--

Img

Invitrogen

50-177-97

--

Img

Invitrogen

50-245-985

--

Img

Invitrogen

50-177-26

--

Description

  • This TULY56 monoclonal antibody reacts with human CD56, also known as Neural Cell Adhesion Molecule (NCAM)
  • CD56 is a highly glycosylated transmembrane molecule expressed by neurons and plays a role in the homotypic adhesion of neural cells
  • In the hematopoietic system, CD56 is expressed on NK cells and a subset of T cells referred to as NKT cells
  • Staining with TULY56 does not block binding of CMSSB, suggesting that the two antibodies recognize different epitopes
  • Additionally, TULY56 performs better after fixation and permeabilization than CMSSB
  • The TULY56 monoclonal antibody crossreacts with Rhesus macaque
  • This TULY56 antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells
  • This can be used at 5 μL (0.06 μg) per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • Super Bright 600 is a tandem dye that can be excited with the violet laser line (405 nm) and emits at 600 nm
  • We recommend using a 610/20 bandpass filter
  • Please make sure that your instrument is capable of detecting this fluorochrome
  • When using two or more Super Bright dye-conjugated antibodies in a staining panel, it is recommended to use Super Bright Complete Staining Buffer (Product No
  • SB-4401) to minimize any non-specific polymer interactions
  • CD56 (NCAM, neural cell adhesion molecule) is a transmembrane glycoprotein of the immunoglobulin family that serves as an adhesive molecule and is ubiquitously expressed in the nervous system in isoforms ranging from 120-180 kDa
  • CD56 is found on T cells and NK cells, and is involved in cell migration, axonal growth, pathfinding and synaptic plasticity
  • Polysialic modification results in reduction of CD56-mediated cell adhesion
  • Through its extracellular region, CD56 mediates homophilic and heterophilic interactions by binding extracellular matrix components such as laminin and integrins
  • CD56 is expressed on most neuroectodermal derived cell lines, tissues and neoplasms such as retinoblastoma, medulloblastoma, astrocytomas and neuroblastoma
  • Further, CD56 is a widely used neuroendocrine marker with a high sensitivity for neuroendocrine tumors and ovarian granulosa cell tumors
  • Diseases associated with CD56 dysfunction include rabies and blastic plasmacytoid dendritic cell neoplasms.